PSB-603
CAY-25637-25 25 mg
Data Sheet: 
SDS:
SDS:
CAS
1092351-10-4
Formulation
A crystalline solid
Purity
≥90%
MW
529
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An adenosine A2B receptor antagonist (Ki = 0.553 nM); selective for adenosine A2B over A1, A2A, and A3 receptors (Kis = >10,000 nM); reduces intracellular calcium concentrations in Jurkat T cells expressing the human A2B receptor (IC50 = 1.13 nM); reduces Zika viral plaque formation (IC50 = 43.8 nM); delays tumor growth and reduces tumor volume and the number of pulmonary metastases in the B16 mouse model of melanoma at 0.25 µg/head, i.p.
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
